Nobel Prize in Medicine awarded for optogenetics
· Health · Sweden
Karl Deisseroth, Peter Hegemann and Georg Nagel won the 2026 Nobel Prize in Physiology or Medicine for discoveries concerning light-gated ion channels and optogenetics, a technique that uses light to control nerve signals. The award committee said the laureates laid the foundation for a new field of brain research. Optogenetics has been used mainly in laboratories, but it has already led to experimental treatments for blindness and Alzheimer's disease. Nature noted that some researchers felt the recognition was overdue. The prize highlights how a research tool can move toward therapies.
Why it matters:Optogenetics is a foundational tool for understanding brain circuits, and its recognition signals that light-controlled gene therapies could become a clinical modality for neurological and vision disorders.
Key points
- Three scientists shared the prize for light-gated ion channels and optogenetics.
- The method uses light to control nerve signals and is mostly a research tool.
- It has led to experimental treatments for blindness and Alzheimer's.
Sources (original reporting)
More stories from this day
- Medicine Nobel awarded for optogenetics, brain's light switch
- Vaxcyte pneumococcal vaccine hits Phase 3 endpoints, stock surges
- Shionogi to buy rare disease biotech IntraBio for $2B
- Roche pays Alector $100M upfront for Parkinson's drug deal
- FDA approves Lilly's Jaypirca as first-line CLL therapy
- Schneider Electric to Buy Software Firm PTC for $22.6 Billion